Drug Profile
Interferon alpha-2b biosimilar - Amega Biotech
Alternative Names: Interferon Alfa-2b biosimilar - Amega BiotechLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Amega Biotech
- Class Antineoplastics; Antivirals; Interferons; Recombinant proteins
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Condylomata acuminata; Follicular lymphoma; Hairy cell leukaemia; Hepatitis C; Kaposi's sarcoma; Malignant melanoma
Most Recent Events
- 14 Aug 2013 Investigation in Condylomata acuminata in Argentina (Parenteral)
- 14 Aug 2013 Investigation in Follicular lymphoma in Argentina (Parenteral)
- 14 Aug 2013 Investigation in Hairy cell leukaemia in Argentina (Parenteral)